Form 4: DocuSign Director Daniel Springer Executes Stock Options and Sells Shares

Director Daniel Springer exercised stock options and sold DocuSign shares on August 2nd and 5th, 2024, according to a Form 4 filing with the SEC.

Summary

• Daniel Springer, a director at DocuSign, executed stock options to acquire shares of common stock at a price of $18.02 on August 2nd and 5th, 2024.
• Following the exercise of these options, Springer sold shares of DocuSign common stock on the open market.
• On August 2nd, 2024, he sold 298,520 shares at an average price of $51.47 and 59,515 shares at an average price of $51.98.
• On August 5th, 2024, he sold 47,482 shares at an average price of $49.65 and 23,501 shares at an average price of $50.21.
• These transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
• After these transactions, Springer directly owns 891,373 shares of DocuSign common stock and indirectly owns 139,825 shares through a trust.
• He also directly owns 592,686 shares of DocuSign common stock via stock options.

Sentiment

Score: 5

Explanation: Neutral. This is a routine filing related to pre-planned stock sales. It doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. However, transactions under 10b5-1 plans are pre-scheduled and may not reflect current sentiment.

Comparison to Industry Standards

• Comparing Daniel Springer's transactions to other SaaS company executives' trading activity is difficult without broader data.
• However, it's common for executives to utilize 10b5-1 plans to diversify their holdings, especially after periods of significant stock appreciation.
• For example, executives at companies like Salesforce (CRM) and Adobe (ADBE) also regularly execute stock options and sales under similar plans.

Key Dates